Sennoside A Ameliorates Diabetic Atherosclerosis by Inhibiting OSCP1/ERK1/2 Pathway to Regulate Endothelial Dysfunction
Crossref DOI link: https://doi.org/10.1007/s11655-026-4226-5
Published Online: 2026-03-23
Published Print: 2026-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Mei-zhi
Ma, Li
Mi, Meng
Jiang, Ya-ning
Wang, Zi-yang
Sun, Yong-ning
Text and Data Mining valid from 2026-03-23
Version of Record valid from 2026-03-23
Article History
Accepted: 24 March 2025
First Online: 23 March 2026
Conflict of Interest
: The authors declare that there is no conflict of interests.